Literature DB >> 6998277

Processing control and cost in bacteriology.

R C Bartlett, C Rutz.   

Abstract

Controlled processing was applied to lower respiratory, wound, and cervicovaginal exudates, and urine. The extent of processing was determined by assessment of quality in direct smears and/or by limits placed on complete identification and antimicrobial susceptibility testing of isolates in mixed cultures. Some specimens were not cultured; others were cultured, but certain isolates were identified by colonial morphologic features only. The time in minutes for performing 22 processing operations was determined. The average number of operations performed with processing control was established along with the total cost per minute of labor expended. A 19% reduction was observed in the time expended with controlled processing relative to projected time expended without processing controls. Urine specimens yielded the greatest saving. Processing control speeds recollection of poor-quality specimens, provides reporting of results of examination of all Gram-stained direct smears, minimizes reporting of information potentially misleading to physicians, and may reduce other health-care costs through improved patient care.

Entities:  

Mesh:

Year:  1980        PMID: 6998277     DOI: 10.1093/ajcp/74.3.287

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Biographical feature: Raymond C. Bartlett, M.D.

Authors:  Andrew B Onderdonk
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

2.  Cost and usefulness of clinical microbiology services.

Authors:  R C Bartlett
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

3.  Biographical Feature: Susan E. Sharp, Ph.D., D(ABMM), F(AAM).

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2022-01-05       Impact factor: 11.677

Review 4.  Evolving approaches to management of quality in clinical microbiology.

Authors:  R C Bartlett; M Mazens-Sullivan; J Z Tetreault; S Lobel; J Nivard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.